Home/ Supplements/ Electrolytes/ D-Ribose 1,000 mg

D-Ribose 1,000 mg

product on market Tablet or Pill Source Naturals Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for D-Ribose 1,000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
20
Servings
Fiber and Other Nutrients
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Carbohydrates
3 Gram(s) (1% DV)
Calcium
56 mg (6% DV)
D-Ribose
3 Gram(s)

Other Ingredients

Dibasic Calcium Phosphate Stearic Acid Magnesium Stearate modified Cellulose Gum Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 3 tablets 1 to 2 times daily with meals.

Warnings & Precautions

Caution: If you are pregnant, may become pregnant, breastfeeding, have gout or any glucose metabolism disorders such as diabetes or hypoglycemia, or if are taking prescription drug, consult your health care professional before using this product.

Do not use if either tamper-evident seal is broken or missing.

Keep out of the reach of children.

Formulation Notes

For workout, energy, and recovery

During strenuous exercise, large amounts of ATP, the body's primary energy-carrying molecule, can be lost from the heart and skeletal muscle cells. D-Ribose is a simple 5-carbon monosaccharide, or pentose sugar, that is used by the body to synthesize nucleotides, nucleic acids, glycogen, and other important metabolic products. Supplemental D-Ribose bypasses the rate limiting steps that are slow to replenish lost nucleotides, thus providing an efficient way to renew energy in a short amount of time.

Contains no yeast, dairy, egg, gluten, soy or wheat. Contains no starch, preservatives, or artificial color, flavor or fragrance.

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 21078 02262 6
DSLD Entry Date2020-03-24
Product TypeFiber and Other Nutrients
FormTablet or Pill
DSLD ID215021
Data Updated2026-04-11
Research

Research Evidence

849
Research Sources
56
Avg Quality
450
Meta Analysis
152
Rct
137
Systematic Review
73
Clinical Trial
11
Regulatory Source
7
Other
7
Guideline
3
Openfda Safety
2
Cochrane Review
2
Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019 PubMed DOI
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Electrolytes →
Compare

Similar Products

View all Electrolytes products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.